Clinical Trials · NCT04525157
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 21
- Start date
- Jun 2014
- Locations
- See registry
- Primary endpoint
- Change in Pigmentation (Total and Individual Body Parts) Using the Vitiligo Area Scoring Index (VASI)